GlycoMimetics Inc (GLYC)
2.155
-0.12
(-5.48%)
USD |
NASDAQ |
Apr 18, 16:00
2.16
0.00 (0.00%)
Pre-Market: 20:00
GlycoMimetics Total Return Level: 2.155 for April 18, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 18, 2024 | 2.155 |
April 17, 2024 | 2.28 |
April 16, 2024 | 2.15 |
April 15, 2024 | 2.255 |
April 12, 2024 | 2.40 |
April 11, 2024 | 2.505 |
April 10, 2024 | 2.45 |
April 09, 2024 | 2.68 |
April 08, 2024 | 2.59 |
April 05, 2024 | 2.75 |
April 04, 2024 | 2.71 |
April 03, 2024 | 2.765 |
April 02, 2024 | 2.96 |
April 01, 2024 | 3.04 |
March 28, 2024 | 3.00 |
March 27, 2024 | 3.18 |
March 26, 2024 | 2.85 |
March 25, 2024 | 2.82 |
March 22, 2024 | 2.93 |
March 21, 2024 | 2.88 |
March 20, 2024 | 3.05 |
March 19, 2024 | 2.93 |
March 18, 2024 | 2.80 |
March 15, 2024 | 2.56 |
March 14, 2024 | 2.61 |
Date | Value |
---|---|
March 13, 2024 | 2.55 |
March 12, 2024 | 2.62 |
March 11, 2024 | 2.56 |
March 08, 2024 | 2.73 |
March 07, 2024 | 2.80 |
March 06, 2024 | 2.90 |
March 05, 2024 | 2.90 |
March 04, 2024 | 3.04 |
March 01, 2024 | 3.01 |
February 29, 2024 | 2.89 |
February 28, 2024 | 2.87 |
February 27, 2024 | 3.02 |
February 26, 2024 | 3.06 |
February 23, 2024 | 2.90 |
February 22, 2024 | 2.93 |
February 21, 2024 | 2.99 |
February 20, 2024 | 3.33 |
February 16, 2024 | 3.22 |
February 15, 2024 | 3.09 |
February 14, 2024 | 3.08 |
February 13, 2024 | 3.09 |
February 12, 2024 | 3.11 |
February 09, 2024 | 3.29 |
February 08, 2024 | 3.20 |
February 07, 2024 | 3.18 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
0.54
Minimum
Jun 16 2022
13.12
Maximum
May 06 2019
2.999
Average
2.40
Median
Mar 26 2020
Total Return Level Benchmarks
Altimmune Inc | 12.98 |
Cellectar Biosciences Inc | 3.04 |
PDS Biotechnology Corp | 2.90 |
Syros Pharmaceuticals Inc | 4.72 |
Precision BioSciences Inc | 10.73 |